Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sarah Romano Insider Profile
4 Followers
Sarah Romano, CFO at Kiora Pharmaceuticals, holds 19.11K shares in First Wave Bio (Ticker: FWBI), holds 22.75K shares in Kiora Pharmaceuticals (Ticker: KPRX). Most recently, Sarah Romano Sold ― shares of First Wave Bio on Apr 03, 2024 for an estimated value of 316.50.
Profitable Transactions
6 out of 8 Profitable Transactions
Average Return
+32.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
The most profitable trade made by Sarah Romano
Sarah Romano's Trading History
Kiora Pharmaceuticals
Feb 11, 2022
CFO
Uninformative Sell
74.52
$10.69K
First Wave Bio
Apr 03, 2024
CFO
Informative Sell
316.50
$52.36K
List of latest transactions for each holding click on a transaction to see Sarah Romano's performance on stock
You May Also Like
Sarah Romano insider profile FAQ
What is the percentage of profitable transactions made by Sarah Romano?
The percentage of profitable transactions made by Sarah Romano is 75%.
What is the average return per transaction made by Sarah Romano?
The average return per transaction made by Sarah Romano is 32.30%.
What stocks does Sarah Romano hold?
Sarah Romano holds: KPRX, FWBI stocks.
What was Sarah Romano’s latest transaction?
Sarah Romano latest transaction was an Informative Sell of $316.50.
What was Sarah Romano's most profitable transaction?
Sarah Romano’s most profitable transaction was an Informative Sell of FWBI stock on April 5, 2023. The return on the trade was 91.30%.
What is Sarah Romano's role in Kiora Pharmaceuticals?
Sarah Romano's role in Kiora Pharmaceuticals is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.